Lasting treatment of facial HIV and non HIV lipoatrophies through the use of SAM GoreTex® malar implants and polyacrylamide hydrogel filler Eutrophill®. About 90 consecutive cases;Traitement durable des lipoatrophies faciales VIH et autres par implants malaires SAM GoreTex® et hydrogel de polyacrylamide (Eutrophill®). À propos de 90 cas consécutifs

Annales de Chirurgie Plastique Esthetique

Volumn 51, Issue 2, 2006, Pages 129-141

  Mole B ^a  

^a NONE   (France)

Author keywords

EPTFE SAM GoreTex ; Facial lipoatrophy; Fillers; HIV; Lipoatrophy; Malar implants; Polyacrylamide hydrogels

Indexed keywords

MONOMER; POLITEF; POLYACRYLAMIDE; POLYACRYLAMIDE GEL; POLYLACTIC ACID; ACRYLIC ACID RESIN; POLYACRYLAMIDE GELS;

ARTICLE; ENZYME DEGRADATION; FEMALE; FOLLOW UP; HALF LIFE TIME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYDROGEL; IMPLANT; INFLAMMATION; INTERSTITIUM; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; METABOLISM; MORBIDITY; POLYMERIZATION; TREATMENT OUTCOME; ADIPOSE TISSUE; ADULT; AGED; ATROPHY; CASE CONTROL STUDY; FACE ASYMMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PLASTIC SURGERY; PROSTHESES AND ORTHOSES; STATISTICS; TIME;

ACRYLIC RESINS; ADIPOSE TISSUE; ADULT; AGED; ATROPHY; CASE-CONTROL STUDIES; FACIAL ASYMMETRY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PROSTHESES AND IMPLANTS; RECONSTRUCTIVE SURGICAL PROCEDURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646344477     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2005.12.015     Document Type: Article

References (16)

1. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-FF8
2. Carr A. HIV Lipodystrophia: risk factors, pathogenesis, diagnosis and management. AIDS 17 suppl 1 (2003) 14-148
3. Carr A., and Law M. An objective lipodystrophie severity grading scale delivered form the lipodystrophy case definition score. J. Acquir. Immune Defic. Syndr. 33 5 (2003) 571-576
4. Wang T. Multicenter evaluation of subutaneous augmentation material implants. Arch. Facial Plast. Surg 5 (2003) 153-154
5. Lemperle G., Morhenn V., and Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast. Surg. 27 (2003) 354-366
6. ® implants in aesthetic surgery of the face. Plast. Reconstr. Surg 90 (1992) 200-206
7. ®. Actualités de chirurgie esthétique (1992), Masson 15-22
8. Môle B. Intérêt des implants prothétiques souples dans la chirurgie du rajeunissement facial. Ann Chir Plast Esthet 34 3 (1989) 227-233
9. ® chin implants, a review of 324 cases. Arch. Facial Plast. Surg 5 (2003) 224-227
10. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesth. Surg. J. 24 1 (2004) 33-45
11. Breiting V., Aasted A., Jorgsesen, Optiz P., and Rosetzsky A. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesthetic Plast. Surg. 28 (2004) 45-53
12. Cheng N., Wang Y., Wang J., Zangh X., and Zhong H. Complications of breast augmentation with injected hydrophilic polyacrylamides gels. Aesthetic Plast. Surg. 26 (2002) 375
13. Qun Q., Xiancheng W., Jiaming S., Ru Z., and Zhifei L. Management for postoperative complications of breast augmentation by injection of polyacrylamide hydrogel. Aesthetic Plast. Surg. 29 (2005) 156-161
14. Protopapa C., Sito G., Caporale D., and Cammarota N. BioAlcamid in drug-induced lipodystrophy. J. Cosmet. Laser Ther. 5 (2003) 226-230
15. Carbonnel E., and Claudy A. Correction ambulatoire des lipoatrophies du VIH par produits de comblement résorbables. À propos de 52 observations. Ann. Dermatol. Venereol. 132 (2005) 521-524
16. ®) to correct facial lipoatrophy in HIV injected patients: result of the opa label study VEGA. AIDS (2003) 2471-2477